124 related articles for article (PubMed ID: 2648721)
1. Detection of adenocarcinoma in peritoneal washings by staining with monoclonal antibody B72.3.
Szpak CA; Soper JT; Thor A; Schlom J; Johnston WW
Acta Cytol; 1989; 33(2):205-14. PubMed ID: 2648721
[TBL] [Abstract][Full Text] [Related]
2. Applications of monoclonal antibodies in clinical cytology as exemplified by studies with monoclonal antibody B72.3. The George N. Papanicolaou award lecture.
Johnston WW
Acta Cytol; 1987; 31(5):537-56. PubMed ID: 3314301
[TBL] [Abstract][Full Text] [Related]
3. Use of a monoclonal antibody (B72.3) as an immunocytochemical adjunct to diagnosis of adenocarcinoma in human effusions.
Johnston WW; Szpak CA; Lottich SC; Thor A; Schlom J
Cancer Res; 1985 Apr; 45(4):1894-900. PubMed ID: 3884146
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic characterization of lung cancers in fine needle aspiration biopsies using monoclonal antibody B72.3.
Johnston WW; Szpak CA; Thor A; Schlom J
Cancer Res; 1986 Dec; 46(12 Pt 1):6462-70. PubMed ID: 3022920
[TBL] [Abstract][Full Text] [Related]
5. The use of monoclonal antibody B72.3 in the management of gynecologic malignancies.
Simpson J; Schlom J
Yale J Biol Med; 1988; 61(4):351-66. PubMed ID: 3055701
[TBL] [Abstract][Full Text] [Related]
6. Tumor-associated glycoprotein (TAG-72) in ovarian carcinomas defined by monoclonal antibody B72.3.
Thor A; Gorstein F; Ohuchi N; Szpak CA; Johnston WW; Schlom J
J Natl Cancer Inst; 1986 Jun; 76(6):995-1006. PubMed ID: 3520078
[TBL] [Abstract][Full Text] [Related]
7. Enhanced tumor binding using immunohistochemical analyses by second generation anti-tumor-associated glycoprotein 72 monoclonal antibodies versus monoclonal antibody B72.3 in human tissue.
Molinolo A; Simpson JF; Thor A; Schlom J
Cancer Res; 1990 Feb; 50(4):1291-8. PubMed ID: 2297774
[TBL] [Abstract][Full Text] [Related]
8. Patterns of reactivity of four novel monoclonal antibodies (B72.3, DF3, B1.1 and B6.2) with cells in human malignant and benign effusions.
Szpak CA; Johnston WW; Lottich SC; Kufe D; Thor A; Schlom J
Acta Cytol; 1984; 28(4):356-67. PubMed ID: 6205527
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic pitfalls of peritoneal washing cytology and the role of cell blocks in their diagnosis.
Selvaggi SM
Diagn Cytopathol; 2003 Jun; 28(6):335-41. PubMed ID: 12768641
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemistry with monoclonal antibody B72.3 as an adjunct in the cytologic diagnosis of pancreatic carcinoma.
Ness MJ; Pour PM; Tempero MA; Linder J
Mod Pathol; 1988 Jul; 1(4):279-83. PubMed ID: 2467286
[TBL] [Abstract][Full Text] [Related]
11. Peritoneal washings in ovarian tumors. Potential sources of error in cytologic diagnosis.
Covell JL; Carry JB; Feldman PS
Acta Cytol; 1985; 29(3):310-6. PubMed ID: 3859128
[TBL] [Abstract][Full Text] [Related]
12. Peritoneal washing cytology. Uses and diagnostic criteria in gynecologic neoplasms.
Ziselman EM; Harkavy SE; Hogan M; West W; Atkinson B
Acta Cytol; 1984; 28(2):105-10. PubMed ID: 6583966
[TBL] [Abstract][Full Text] [Related]
13. Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3.
Thor A; Ohuchi N; Szpak CA; Johnston WW; Schlom J
Cancer Res; 1986 Jun; 46(6):3118-24. PubMed ID: 3516392
[TBL] [Abstract][Full Text] [Related]
14. Reactivity of monoclonal antibody DF3 with a high molecular weight antigen expressed in human ovarian carcinomas.
Friedman EL; Hayes DF; Kufe DW
Cancer Res; 1986 Oct; 46(10):5189-94. PubMed ID: 3530435
[TBL] [Abstract][Full Text] [Related]
15. Identification of adenocarcinoma in cytospin preparations of effusions using monoclonal antibody B72.3.
Martin SE; Moshiri S; Thor A; Vilasi V; Chu EW; Schlom J
Am J Clin Pathol; 1986 Jul; 86(1):10-8. PubMed ID: 3524191
[TBL] [Abstract][Full Text] [Related]
16. Autoradiographic evaluation of radiolabeled monoclonal antibody B72.3 distribution in tumor and lymph nodes of adenocarcinoma patients.
Roselli M; Hitchcock CL; Molinolo A; Milenic DE; Colcher D; Martin EW; Hinkle GH; Schlom J
Anticancer Res; 1995; 15(3):975-84. PubMed ID: 7645989
[TBL] [Abstract][Full Text] [Related]
17. Significance of peritoneal washings in gynecologic oncology. The experience with 901 intraoperative washings at an academic medical center.
Mathew S; Erozan YS
Arch Pathol Lab Med; 1997 Jun; 121(6):604-6. PubMed ID: 9199626
[TBL] [Abstract][Full Text] [Related]
18. Tumor-associated glycoprotein expression in salivary gland mucoepidermoid carcinomas: an immunohistochemical study using the monoclonal antibody B72.3.
Roa RA; Hruban RH; McKenzie P; Richtsmeier W
Laryngoscope; 1994 Mar; 104(3 Pt 1):304-8. PubMed ID: 8127187
[TBL] [Abstract][Full Text] [Related]
19. Generation and characterization of B72.3 second generation monoclonal antibodies reactive with the tumor-associated glycoprotein 72 antigen.
Muraro R; Kuroki M; Wunderlich D; Poole DJ; Colcher D; Thor A; Greiner JW; Simpson JF; Molinolo A; Noguchi P
Cancer Res; 1988 Aug; 48(16):4588-96. PubMed ID: 3396010
[TBL] [Abstract][Full Text] [Related]
20. Cytology of peritoneal washings in gynecologic patients. Diagnostic criteria and pitfalls.
Ravinsky E
Acta Cytol; 1986; 30(1):8-16. PubMed ID: 3456188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]